![Joe Rayne](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Joe Rayne
Investor Relations Contact chez
NUVATION BIO INC.
Profil
Joe Rayne is currently Head-Investor Relations at Nuvation Bio, Inc. Formerly, Mr. Rayne was Head-Investor Relations at Inotek Pharmaceuticals Corp.
and Vice President at Argot Partners LLC from 2017 to 2021.
Postes actifs de Joe Rayne
| Sociétés | Poste | Début |
|---|---|---|
| NUVATION BIO INC. | Investor Relations Contact | - |
Anciens postes connus de Joe Rayne
| Sociétés | Poste | Fin |
|---|---|---|
Argot Partners LLC
 Argot Partners LLC Miscellaneous Commercial ServicesCommercial Services Operates as a strategic communications consultancy | Corporate Officer/Principal | 01/08/2021 |
Inotek Pharmaceuticals Corp.
 Inotek Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Engages in the development, discovery and commercialization of therapies for glaucoma and other diseases of the eye | Investor Relations Contact | - |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
20
Relations au 1er degré
3
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 3 |
|---|---|
Inotek Pharmaceuticals Corp.
Inotek Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Engages in the development, discovery and commercialization of therapies for glaucoma and other diseases of the eye | Health Technology |
Argot Partners LLC
Argot Partners LLC Miscellaneous Commercial ServicesCommercial Services Operates as a strategic communications consultancy | Commercial Services |
Nuvation Bio, Inc.
 Nuvation Bio, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company which develops oncology related novel therapeutic candidates | Health Technology |
